Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

395 ARTÍCULOS , VIENDO DEL 31 AL 45

Association of Vascular Risk Factors With β-Amyloid Peptide and Tau Burdens in Cognitively Unimpaired Individuals and Its Interaction With Vascular Medication Use

Köbe T, Gonneaud J, Pichet Binette A, Meyer PF, McSweeney M, Rosa-Neto P, Breitner JCS, Poirier J, Villeneuve S; Presymptomatic Evaluation of Experimental or Novel Treatments for Alzheimer Disease (PREVENT-AD) Research Group.

JAMA Netw Open. 2020 Feb 5;3(2):e1920780. doi: 10.1001/jamanetworkopen.2019.20780.

Examination of the influence of cedar fragrance on cognitive function and behavioral and psychological symptoms of dementia in Alzheimer type dementia

Takahashi Y, Shindo S, Kanbayashi T, Takeshima M, Imanishi A, Mishima K.

Neuropsychopharmacol Rep. 2020 Mar;40(1):10-15. doi: 10.1002/npr2.12096. Epub 2020 Feb 9.

Risk of Alzheimer's Disease in Obstructive Sleep Apnea Patients With or Without Treatment: Real-World Evidence

Tsai MS, Li HY, Huang CG, Wang RYL, Chuang LP, Chen NH, Liu CH, Yang YH, Liu CY, Hsu CM, Cheng WN, Lee LA.

Laryngoscope. 2020 Sep;130(9):2292-2298. doi: 10.1002/lary.28558. Epub 2020 Feb 11.

Donepezil plus memantine versus donepezil alone for treatment of concomitant Alzheimer's disease and chronic obstructive pulmonary disease: a retrospective observational study

Cao Y, Qian L, Yu W, Li T, Mao S, Han G.

J Int Med Res. 2020 Feb;48(2):300060520902895. doi: 10.1177/0300060520902895.

Central and Peripheral Metabolic Defects Contribute to the Pathogenesis of Alzheimer's Disease: Targeting Mitochondria for Diagnosis and Prevention

Peng Y, Gao P, Shi L, Chen L, Liu J, Long J.

Antioxid Redox Signal. 2020 Jun 1;32(16):1188-1236. doi: 10.1089/ars.2019.7763. Epub 2020 Mar 16.

Magnetic Resonance Texture Analysis in Alzheimer's disease

Cai JH, He Y, Zhong XL, Lei H, Wang F, Luo GH, Zhao H, Liu JC.

Acad Radiol. 2020 Dec;27(12):1774-1783. doi: 10.1016/j.acra.2020.01.006. Epub 2020 Feb 10.

Biosensors on the road to early diagnostic and surveillance of Alzheimer's disease

Carneiro P, Morais S, do Carmo Pereira M.

Talanta. 2020 May 1;211:120700. doi: 10.1016/j.talanta.2019.120700. Epub 2020 Jan 3.

Behavioural and psychological symptoms of dementia in mouse models of Alzheimer's disease-related pathology

Kosel F, Pelley JMS, Franklin TB.

Neurosci Biobehav Rev. 2020 May;112:634-647. doi: 10.1016/j.neubiorev.2020.02.012. Epub 2020 Feb 15.

Examining the benefits and harms of Alzheimer's disease screening for family members of older adults: study protocol for a randomized controlled trial

Fowler NR, Head KJ, Perkins AJ, Gao S, Callahan CM, Bakas T, Suarez SD, Boustani MA.

Trials. 2020 Feb 19;21(1):202. doi: 10.1186/s13063-019-4029-5.

Safety and Neuroprotective Efficacy of Palm Oil and Tocotrienol-Rich Fraction from Palm Oil: A Systematic Review

Ismail M, Alsalahi A, Imam MU, Ooi J, Khaza'ai H, Aljaberi MA, Shamsudin MN, Idrus Z.

Nutrients. 2020 Feb 18;12(2):521. doi: 10.3390/nu12020521.

Genetic architecture of neurodegenerative dementias

Clarimon J, Moreno-Grau S, Cervera-Carles L, Dols-Icardo O, Sánchez-Juan P, Ruiz A.

Neuropharmacology. 2020 May 15;168:108014. doi: 10.1016/j.neuropharm.2020.108014. Epub 2020 Feb 17.

Alzheimer's disease: phenotypic approaches using disease models and the targeting of tau protein

Lauretti E, Praticò D.

Expert Opin Ther Targets. 2020 Apr;24(4):319-330. doi: 10.1080/14728222.2020.1737012. Epub 2020 Mar 6.

The prevalence of Alzheimer's disease in the Chinese Han population: a meta-analysis

Zhao X, Li X.

Neurol Res. 2020 Apr;42(4):291-298. doi: 10.1080/01616412.2020.1716467. Epub 2020 Mar 6.

Nanoparticles as contrast agents for the diagnosis of Alzheimer's disease: a systematic review

Ulanova M, Poljak A, Wen W, Bongers A, Gloag L, Gooding J, Tilley R, Sachdev P, Braidy N.

Nanomedicine (Lond). 2020 Mar;15(7):725-743. doi: 10.2217/nnm-2019-0316. Epub 2020 Mar 6.

Relationships between amyloid levels, glucose metabolism, morphologic changes in the brain and clinical status of patients with Alzheimer's disease

Thientunyakit T, Sethanandha C, Muangpaisan W, Chawalparit O, Arunrungvichian K, Siriprapa T, Vichianin Y, Kamal S, Suppasilp C, Thongpraparn T, Chanachai R, Gelovani JG.

Ann Nucl Med. 2020 May;34(5):337-348. doi: 10.1007/s12149-020-01453-y. Epub 2020 Mar 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias